Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-12 Sale |
2024-09-20 4:20 pm |
NeuroBo Pharmaceuticals Inc. | NRBO | DONG-A ST CO. LTD 10% Owner |
407 | $3.75 | $1,526 | 11,709,117 (Direct) |
View |
| 2024-06-23 Purchase(A) |
2024-07-10 11:11 am |
NeuroBo Pharmaceuticals Inc. | NRBO | DONG-A ST CO. LTD 10% Owner |
2,544,530 | $3.93 | $10,000,003 | 5,348,229 (Direct) |
View |
| 2024-06-23 Purchase |
2024-06-25 4:16 pm |
NeuroBo Pharmaceuticals Inc. | NRBO | DONG-A ST CO. LTD 10% Owner |
2,544,530 | $3.13 | $7,964,379 | 5,348,229 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Tax Withholding |
2025-03-04 4:01 pm |
N/A N/A |
MetaVia Inc. | MTVA | Woodworth Marshall H Chief Financial Officer |
3,417 | $1.46 | 30,079 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:01 pm |
N/A N/A |
MetaVia Inc. | MTVA | Kim Hyung Heon CEO & President |
2,795 | $1.46 | 61,004 (Direct) |
View |
| 2024-11-30 Tax Withholding |
2024-12-02 5:31 pm |
N/A N/A |
MetaVia Inc. | MTVA | Kim Hyung Heon CEO & President |
2,867 | $2.55 | 63,799 (Direct) |
View |
| 2024-08-11 Tax Withholding |
2024-08-13 4:01 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Kim Hyung Heon CEO & President |
11,467 | $3.6 | 66,666 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-07 7:26 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Salsbury Michael Director |
5,051 | $0 | 17,552 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-07 7:26 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | GROVES JASON L Director |
5,051 | $0 | 17,552 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-07 7:25 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | KOVEN ANDREW I Director |
5,051 | $0 | 17,552 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-07 7:25 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Glickman Mark A Director |
5,051 | $0 | 9,740 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-07 7:24 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | STRICKLAND D GORDON Director |
5,051 | $0 | 17,552 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-07 7:24 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Tursi James Patrick Director |
5,051 | $0 | 9,072 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 9:20 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Woodworth Marshall H Chief Financial Officer |
33,496 | $0 | 33,496 (Direct) |
View |
| 2023-12-01 Option Award |
2023-12-04 5:12 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Tursi James Patrick Director |
32,157 | $0 | 32,157 (Direct) |
View |
| 2023-08-11 Option Award |
2023-08-14 4:10 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Kim Hyung Heon CEO & President |
625,064 | $0 | 625,064 (Direct) |
View |
| 2023-07-27 Option Award |
2023-07-28 06:19 am |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | KOVEN ANDREW I Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-07-27 Option Award |
2023-07-28 06:17 am |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Salsbury Michael Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-07-27 Option Award |
2023-07-28 06:15 am |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | STRICKLAND D GORDON Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-07-27 Option Award |
2023-07-28 06:13 am |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | GROVES JASON L Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-07-27 Option Award |
2023-07-28 06:11 am |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Glickman Mark A Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-07-27 Option Award |
2023-07-28 06:08 am |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner |
100,000 | $0 | 302,013 (Direct) |
View |
| 2022-07-26 Other(A) |
2023-07-28 06:02 am |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner |
4,671 | $0 | 9,342 (Indirect) |
View |
Ownership |
2022-11-22 4:46 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner |
0 | $0 | 1,220,502 (Indirect) |
View |
| 2022-07-26 Other |
2022-07-28 9:23 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | E&Investment Inc. E&Healthcare Investment Fund II 10% Owner |
1,445,267 | $0 | 7,461,936 (Indirect) |
View |
| 2022-07-26 Other |
2022-07-28 4:03 pm |
N/A N/A |
NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner |
1,445,267 | $0 | 7,365,585 (Indirect) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:14 pm |
N/A 2032-06-09 |
NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:12 pm |
N/A 2032-06-09 |
NeuroBo Pharmaceuticals Inc. | NRBO | GROVES JASON L Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:28 pm |
N/A 2032-06-09 |
NeuroBo Pharmaceuticals Inc. | NRBO | Kim Hyung Heon Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:25 pm |
N/A 2032-06-09 |
NeuroBo Pharmaceuticals Inc. | NRBO | Kang Richard Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:23 pm |
N/A 2032-06-09 |
NeuroBo Pharmaceuticals Inc. | NRBO | STRICKLAND D GORDON Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:22 pm |
N/A 2032-06-09 |
NeuroBo Pharmaceuticals Inc. | NRBO | Salsbury Michael Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:21 pm |
N/A 2032-06-09 |
NeuroBo Pharmaceuticals Inc. | NRBO | KOVEN ANDREW I Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-01-27 Option Award |
2022-02-02 5:51 pm |
N/A 2032-01-27 |
NeuroBo Pharmaceuticals Inc. | NRBO | STRICKLAND D GORDON Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-11-03 Option Award |
2021-11-04 4:57 pm |
N/A 2031-11-03 |
NeuroBo Pharmaceuticals Inc. | NRBO | Price Ben Gil CEO and President |
616,666 | $0 | 616,666 (Direct) |
View |